Satisfaction Assessment After Axillary Block

NCT ID: NCT04305847

Last Updated: 2020-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Satisfaction assessment at 24 and 48 hours post operatively, after Axillary Brachial Plexus Block for Distal Arm Surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion after distal Arm Surgery performed under Axillary Brachial Plexus Block.

Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Satisfaction, Patient

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Anaesthesia, regional axillary brachial plexus block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Qual'AXI group

patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block

perioperative satisfaction assessment

Intervention Type OTHER

Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

perioperative satisfaction assessment

Satisfaction assessment at 24 and 48 hours post operatively by self-administered survey questionnaire based on different scales: Evan-LR, Net Promotor Score, Satisfaction score.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients for whom distal arm surgery was performed under Axillary Brachial Plexus Block

Exclusion Criteria

* Refusal, inability to consent
* inability to fill self-administered survey questionnaire
* pregnancy and breastfeeding
* surgery \> 2 hours
* second surgical site requiring anaesthesia or analgesia
* chronic use of analgesia (including opioids) or illegal drugs
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Besançon

Besançon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francis Berthier, MD

Role: CONTACT

Phone: 0033381218980

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francis BERTHIER, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P/2020/480

Identifier Type: -

Identifier Source: org_study_id